NCT00383396View on ClinicalTrials.gov

Efficacy of Topical Cyclosporine 0.05% in the Prevention of Ocular Surface Inflammation Secondary to Pterygia

PHASE4CompletedINTERVENTIONAL

Timeline

Start Date

Not specified

Conditions

Pterygia

Interventions

DRUG

Topical Cyclosporine

Trial Locations (1)

33426

Dr. Schechter, Boynton Beach

Sponsors

Lead Sponsor

Innovative Medical

All Listed Sponsors

lead

Innovative Medical

INDUSTRY

NCT00383396 - Efficacy of Topical Cyclosporine 0.05% in the Prevention of Ocular Surface Inflammation Secondary to Pterygia | Biotech Hunter | Biotech Hunter